share_log

Pfizer | SC TO-I/A: Third party tender offer statement (Amendment)

Pfizer | SC TO-I/A: Third party tender offer statement (Amendment)

輝瑞 | SC TO-I/A：發行招標公告
美股SEC公告 ·  09/13 16:52

牛牛AI助理已提取核心訊息

Pfizer Inc. has successfully completed its tender offer to modify eligible Performance Share Awards (PSAs) and Total Shareholder Return Units (TSRUs) as detailed in Amendment No. 2 to the Tender Offer Statement on Schedule TO. The offer, which was filed with the Securities and Exchange Commission (SEC), expired on September 12, 2024, at 11:59 p.m. Eastern Time. Following the expiration, Pfizer accepted for modification a total of 1,359,772 Eligible PSAs and 30,360,402 Eligible TSRUs. The modified awards are now subject to the terms and conditions of the 2019 Plan and the applicable award agreements. The vesting and other terms of the Modified PSAs and Modified TSRUs are described in the Schedule TO and the Modification Offer. This final amendment was filed to report the results of the tender offer and to satisfy the disclosure requirements of Rule 13e-4(c)(4) under the Securities Exchange Act of 1934.
Pfizer Inc. has successfully completed its tender offer to modify eligible Performance Share Awards (PSAs) and Total Shareholder Return Units (TSRUs) as detailed in Amendment No. 2 to the Tender Offer Statement on Schedule TO. The offer, which was filed with the Securities and Exchange Commission (SEC), expired on September 12, 2024, at 11:59 p.m. Eastern Time. Following the expiration, Pfizer accepted for modification a total of 1,359,772 Eligible PSAs and 30,360,402 Eligible TSRUs. The modified awards are now subject to the terms and conditions of the 2019 Plan and the applicable award agreements. The vesting and other terms of the Modified PSAs and Modified TSRUs are described in the Schedule TO and the Modification Offer. This final amendment was filed to report the results of the tender offer and to satisfy the disclosure requirements of Rule 13e-4(c)(4) under the Securities Exchange Act of 1934.
輝瑞公司已成功完成其要約收購，修改了符合條件的業績股份獎勵（PSAs）和總股東回報單位（TSRUs），詳見《修改要約聲明附表TO表第2號修正案》。該要約已提交給美國證券交易委員會（SEC），於2024年9月12日東部時間晚上11:59到期。要約到期後，輝瑞公司接受修改了共計1,359,772份符合條件的PSAs和30,360,402份符合條件的TSRUs。修改後的股份獎勵現受2019年計劃及適用的獎勵協議條款約束。修改後的PSAs和TSRUs的獲權和其他條款已在TO表和修改要約中描述。此最終修正案提交是爲了報告要約的結果，並滿足1934年證券交易法第13e-4(c)(4)規定的披露要求。
輝瑞公司已成功完成其要約收購，修改了符合條件的業績股份獎勵（PSAs）和總股東回報單位（TSRUs），詳見《修改要約聲明附表TO表第2號修正案》。該要約已提交給美國證券交易委員會（SEC），於2024年9月12日東部時間晚上11:59到期。要約到期後，輝瑞公司接受修改了共計1,359,772份符合條件的PSAs和30,360,402份符合條件的TSRUs。修改後的股份獎勵現受2019年計劃及適用的獎勵協議條款約束。修改後的PSAs和TSRUs的獲權和其他條款已在TO表和修改要約中描述。此最終修正案提交是爲了報告要約的結果，並滿足1934年證券交易法第13e-4(c)(4)規定的披露要求。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間